Friday, July 03, 2009
New Embryonic Stem Cells Developed from Prime Mouse Strain
Researchers from the Wellcome Trust Sanger Institute, the University of California at Davis, and Harvard University have isolated stable, highly germline-competent embryonic stem (ES) cells from the C57BL/6N genetic background. These cells are ideal for high-throughput genetic manipulation and are the foundation for two large-scale knockout programmes that will provide targeted C57BL/6 ES cells for the scientific community.
Top Stories
Business & Industry
11 June 2009
| Mergers & Acquisitions:

